K Adamus, W Pajdak
Index: Scand. J. Clin. Lab. Invest. 54(5) , 353-9, (1994)
Full Text: HTML
The fibrinolytic system was studied in normal human plasma containing increasing concentrations of acetone up to 23.4 mmol l-1. Fibrinolytic activity measured as euglobulin clot lysis time [ECLT] and amidase activities toward chromogenic peptide substrates H-D-Valyl-L-Leucyl-L-Lysine-p-nitroanilide 2 HCl [S-2251], designed for plasmin determination, H-D-Valyl-L-Phenylalanyl-L-Lysine-p-nitroanilide 2 HCl [S-2390], designed for the determination of t-PA in plasma via plasminogen activation and H-D-Prolyl-L-Phenyl-Alanyl-L-Arginine-p-nitro-anilide 2 HCl [S-2302], designed for the determination of kallikrein and activated Hageman factor, increased when 15.7 mmol l-1 concentration of acetone was reached. A parallel increase of esterolytic [substrate: naphthol-AS-acetate] activity was observed in euglobulin fractions. Crossed immunoelectrophoresis [CIE] revealed changes in fibrinogen profiles of plasma enriched with acetone as compared to native plasma. These findings suggest that acetone present in plasma in concentrations comparable to those found in some pathological states might activate fibrinolytic system.
Structure | Name/CAS No. | Molecular Formula | Articles |
---|---|---|---|
![]() |
H-D-Val-Leu-Lys-pNA · 2 HCl
CAS:62354-43-2 |
C23H40Cl2N6O5 |
The potential mechanism for the effect of heparin on tissue ...
2000-03-01 [Thromb. Res. 97(5) , 349-58, (2000)] |
Bovine erythrocyte haemolysates enhance plasminogen activati...
1997-02-01 [Vet. Res. Commun. 21(2) , 75-84, (1997)] |
Gossypol-induced inhibition of plasminogen activator activit...
1999-12-01 [Andrologie 31(6) , 355-9, (1999)] |
Development of plasma kallikrein selective inhibitors.
1999-01-01 [Biopolymers 51(1) , 41-50, (1999)] |
Activating effect of the plasminogen activators on plasminog...
1995-08-15 [Thromb. Res. 79(4) , 423-8, (1995)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved